Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3541 studies found for:    "Antineoplastic Agents, Alkylating"
Show Display Options
Rank Status Study
1 Completed A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients
Condition: HIV Infections
Interventions: Drug: Nelfinavir mesylate;   Drug: Lamivudine;   Drug: Filgrastim;   Drug: Stavudine;   Drug: Cyclophosphamide
2 Recruiting Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
Conditions: Acute Myeloid Leukemia;   Acute Lymphoid Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Chronic Lymphocytic Leukemia;   Immune System Diseases
Interventions: Drug: Cyclophosphamide;   Drug: Busulfan;   Drug: Fludarabine monophosphate;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Procedure: Allogeneic hematopoietic stem cell transplantation
3 Completed A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Endocrine Gland Neoplasms;   Neoplasms by Site;   Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Genital Diseases, Female
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
4 Terminated
Has Results
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma
Condition: Anaplastic Large Cell Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin hydrochloride;   Drug: vincristine sulfate;   Drug: prednisone;   Drug: SGN-30
5 Recruiting Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors
Condition: Breast Cancer
Interventions: Device: Focused Microwave Thermotherapy;   Drug: Chemotherapy (control)
6 Completed A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer
Conditions: Breast Neoplasms;   Neoplasms;   Neoplasms by Site;   Breast Diseases;   Skin Diseases
Intervention: Drug: ET743
7 Unknown  Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Condition: Cancer
Interventions: Drug: cyclophosphamide;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: cryosurgery
8 Active, not recruiting Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Mesna;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Ara-C;   Drug: Dexamethasone;   Drug: G-CSF;   Drug: Doxil
9 Completed Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
Conditions: Glomerulonephritis, Membranous;   Glomerulosclerosis, Focal
Interventions: Drug: prednisolone and mycophenolate mofetil;   Drug: prednisolone and chlorambucil
10 Unknown  Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)
Condition: Aplastic Anemia
Intervention: Other: Cyclophosphosphamide, TBI
11 Unknown  The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
Condition: Breast Cancer
Intervention: Drug: epirubicin, cyclophosphamide, paclitaxel, carboplatin, G-CSF
12 Completed
Has Results
Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Ixabepilone;   Drug: Paclitaxel;   Drug: Cyclophosphamide;   Drug: Doxorubicin
13 Completed A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Condition: Lymphoblastic Leukemia, Acute, Childhood
Intervention: Drug: Clofarabine incorporated into a 5-drug regimen
14 Active, not recruiting Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cisplatin;   Drug: bevacizumab;   Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: paclitaxel
15 Recruiting Multicenter Transplant Study for Fanconi Anemia
Condition: Fanconi Anemia
Interventions: Drug: Chemotherapy Preparative Regimen;   Biological: Miltenyi CliniMACS
16 Active, not recruiting Efficacy Study of Adjuvant Chemotherapy for Chinese Primary Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: Docetaxel Cyclophosphamide;   Drug: Cyclophosphamide Fluorouracil Epirubicin Docetaxel;   Drug: Epirubicin Cyclophosphamide Paclitaxel
17 Recruiting Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Conditions: HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: capecitabine;   Drug: cyclophosphamide;   Drug: lapatinib ditosylate;   Biological: trastuzumab;   Other: laboratory biomarker analysis
18 Unknown  Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas
Conditions: Leiomyosarcoma;   Liposarcoma
Intervention: Drug: Gemcitabine + Trabectedin
19 Active, not recruiting Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Condition: Multiple Myeloma
Intervention: Drug: High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)
20 Unknown  Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: mitoxantrone hydrochloride;   Drug: prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years